DOCSLIB.ORG

Primary Antibody Responses to a Well-Defined and Unique Hapten Are

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Primary Antibody Responses to a Well-Defined and Unique Hapten Are Proc. Nati. Acad. Sci. USA Vol. 83, pp. 2604-2608, April 1986 Immunology Primary antibody responses to a well-defined and unique hapten are not enhanced by preimmunization with carrier: Analysis in a viral model SHIV CHARAN GUPTA*, HANS HENGARTNER, AND ROLF M. ZINKERNAGELt Department of Experimental Pathology, Institute of Pathology, University Hospital Zlrich, 8091 Zdrich, Switzerland Communicated by A. Frey-Wyssling, December 5, 1985 ABSTRACT We used a viral model to reexamine classical been studied particularly carefully in influenza viruses experiments showing that mice previously primed with a (16-19) or vesicular stomatitis viruses (VSV, refs. 20-23), "carrier" molecule alone and then challenged with the carrier- because they are the structures used for the attachment ofthe hapten conjugate exhibited an enhanced antihapten antibody virus to cells. Antibodies against these unique determinants response. Mice were primed with live or UV-inactivated are virus-neutralizing antibodies. vesicular stomatitis virus (VSV) Indiana (bId) serotype with or The VSV glycoprotein G is the major component of the without complete Freund's adjuvant. After challenge with VSV viral coat (20). It is the only viral antigen expressed on New Jersey (NJ), these mice developed a secondary-type IgG infected cells and is the target antigen for VSV-specific response, measured by antibody binding in an ELISA, against cytotoxic T cells (20, 21, 24). It has been shown unequivo- both VSV-Ind and VSV-NJ. The same result was found for the cally that the determinant involved in virus neutralization by reciprocal experiments where mice were primed with VSV-NJ. antibody is located on G: monoclonal antibodies capable of Similarly, when mice were primed with live VSV, UV-inac- neutralizing virus only precipitate G protein (21, 22), and tivated VSV, or purified VSV glycoprotein G of Ind or NJ animals immunized with purified G are protected against serotype and later were challenged with dinitrophenyl (N2ph)- VSV and generate neutralizing antibodies (21-23). conjugated, UV-inactivated VSV or with N2ph-conjugated G In analogy to the classical hapten-carrier models, the protein of either serotype, they exhibited a secondary-type neutralizing determinant on the VSV glycoprotein would anti-N2ph antibody response as demonstrated by the binding of represent a hapten whereas the rest of the major glycopro- IgG to dinitrophenylated bovine serum albumin measured by teins or other constant viral structures represent the carrier ELISA. In contrast, when neutralizing antibody responses moiety. T-cell crossreactivity for the carrier is illustrated by were monitored, VSV-Ind-primed mice challenged with VSV- the fact that many cytotoxic T cells to VSV or influenza do NJ developed a strictly primary type of anti-VSV-NJ response not of the and vice versa. We conclude that preexistent helper T cells readily distinguish between different serotypes specific for shared carrier determinants do not improve virgin same virus type (24-29). We have analyzed the antibody B-cell responses specific for "new," unique determinants that responses in VSV-primed mice, after challenge with homol- are the target for the biologically relevant neutralizing anti- ogous or heterologous serotype, by (i) ELISA, revealing bodies. These findings suggest that priming of B cells rather crossreactive antibodies binding to the whole virion or than ofhelper T cells may be ofimportance to induce protective purified glycoprotein, and (it) serum neutralization assays, immunity mediated by antibodies. monitoring the type of antibody response against the unique determinants involved in neutralization. We show that mice Initiation and maintenance of an IgG antibody response primed with one serotype of VSV do not develop an en- against most antigens require T- and B-cell collaboration hanced neutralizing antibody response when challenged with (1-5). It is thought that T cells recognize the so-called carrier a heterologous VSV, whereas antibody responses to shared determinants of an antigen, whereas B cells are thought to determinants measured by ELISA are of secondary type. recognize the same or additional determinants, usually called haptens (1-6). Classical experiments have established that MATERIALS AND METHODS mice primed with the carrier part of an antigenic molecule, upon immunization with a hapten conjugated to the same Mice. DBA/2 mice, from the Institut fir Zuchthygiene, carrier molecule, respond with an enhanced B-cell response Zurich, were used throughout these experiments. against the hapten when compared with unprimed mice (7-9). Virus. VSV-Ind (serotype Indiana) and VSV-NJ (serotype Most experiments on the relative role of carrier-primed T New Jersey) virus stocks were prepared in BHK-21 cells as cells in antihapten responses of primed or unprimed B cells described (30). Concentration and purification of the virus have used artificial antigens such as 2,4-dinitrophenyl were carried out according to established procedures (21). (N2ph)-conjugated keyhole limpet hemocyanin, 2,4,6- Preparation of Purified Surface Glycoprotein G. The prep- trinitrophenyl (N3ph)-conjugated bovine gamma globulin, or aration ofG protein has been described (21). In brief, purified heterologous erythrocytes (7-14). Our studies were aimed at VSV-Ind and VSV-NJ were treated with Triton X-100 at a evaluating these rules in an antiviral immune response. final concentration of2% (vol/vol). The Triton/virus mixture Viruses that belong to the same type but are subdivided was stirred at room temperature for 60 min and then centri- according to their serotypes (species or subtype) (15) share fuged at 140,000 x g at 5°C for 90 min. The supernatant many antigenic determinants on various structural gene products; they also possess unique determinants, usually on Abbreviations: VSV, vesicular stomatitis virus; Ind, serotype Indi- major viral glycoproteins. These unique determinants have ana; NJ, serotype New Jersey; G, major viral coat glycoprotein; CFA, complete Freund's adjuvant; pfu, plaque-forming unit(s); N2ph, 2,4-dinitrophenyl; N3ph, 2,4,6-trinitrophenyl. The publication costs of this article were defrayed in part by page charge *Present address: Department of Veterinary Microbiology, Haryana payment. This article must therefore be hereby marked "advertisement" Agricultural University, Hissar, Haryana, India-125004. in accordance with 18 U.S.C. §1734 solely to indicate this fact. tTo whom reprint requests should be addressed. 2604 Downloaded by guest on September 25, 2021 Immunology: Gupta et al. Proc. Natl. Acad. Sci. USA 83 (1986) 2605 containing G was checked for purity by polyacrylamide gel Switzerland) at 40C overnight. The plates were then washed electrophoresis (20). five times with phosphate-buffered saline containing 0.05% Immunization. For primary or secondary immunization Tween 20 (PBS/Tween). Sera diluted in PBS/Tween (100 ,uI with live virus, 106 plaque-forming units (pfu) of VSV-Ind or per well) were incubated in the antigen-coated plates for 2 hr VSV-NJ were given i.v. Virus inactivated by UV light was at room temperature. Plates were again washed five times injected i.p. at a dose of 108 pfu, emulsified in complete with PBS/Tween and then were incubated with goat anti- Freund's adjuvant (CFA). The optimal doses ofVSV or VSV mouse IgG, labeled with horseradish peroxidase (Tago 4143, glycoprotein coupled with N2ph were predetermined by Burlingame, CA) and diluted in PBS/Tween (100 Al per well), titration in vivo; for primary immunization, 20 jig of antigen for 2 hr at room temperature. The plates were washed again was injected with CFA i.p., and for secondary immuniza- in PBS/Tween, and 200 ,ul of substrate [2 mg of 2,2'-azino- tions, the same amount was given i.v. without CFA. bis(3-ethylbenzthiazolinesulfonate) (Boehringer Mannheim; Coupling of VSV-Ind and VSV-NJ with N2ph. Dinitrophen- ref. 6) in 20 ml of 0.1 M NaH2PO4 (pH 4.0) and 15 Al of 30%6 ylated VSV-Ind (Ind-N2ph) and VSV-NJ (NJ-N2ph) were H2021 was added per well. The optical density at 405 nm prepared according to standard methods (31). In brief, virus was measured with a micro-ELISA reader (Virion AG, purified on sucrose gradients was mixed with sodium 2,4- Ruschlikon, Switzerland). dinitrobenzenesulfonate at pH 8.0. The mixture was stirred For the determination of anti-N2ph antibodies, 1.0 jug of overnight, protected from light and at room temperature. The coupled bovine serum albumin (BSA-N2ph, a gift from H. mixture was centrifuged at 5,000 x g to remove insoluble Binz, Institute of Virology and Immunology, University of material and then the hapten-modified virus was resediment- Zilrich) was used per well ofa microwell plate. Before adding ed. To wash off excess sodium dinitrobenzenesulfonate, the the second antibody conjugate, the wells were pretreated virus was suspended in Hanks' balanced salts solution (BSS) with 1.0% normal goat serum for 30 min at room temperature; and resedimented three times. The sedimented dinitro- otherwise the same protocol was used as described for the phenylated virus was collected in 500 jul of BSS and the ELISA to determine anti-VSV antibody titers. optimal dilution for the immunization ofmice was determined in a preliminary experiment in vivo. RESULTS Coupling of VSV-Ind Glycoprotein and VSV-NJ Glycopro- tein with N2ph. Reaction ofVSV-Ind and VSV-NJ G proteins Primary Antibody Responses Against VSV. After primary with N2ph was carried out essentially as described for the immunization with VSV-Ind and VSV-NJ, serotype-specific whole virus (31), except that the free N2ph was removed by IgM antibodies (2-mercaptoethanol-sensitive serum neutral- filtration through Amicon YM10 filters (Amicon). The opti- ization antibody) were detectable on day 2 and reached mal amounts of G(Ind)-N2ph and G(NJ)-N2ph for the immu- maximal levels on day 6 (Fig. 1 A and D). IgM antibody nization of mice were predetermined in vivo. responses dropped below a detectable level by about 3 weeks Serum Neutralization Test.
Load more

Recommended publications
  • Involvement of Haptens in Allergic and Non-Allergic Hypersensitivity
    Polish J. of Environ. Stud. Vol. 18, No 3 (2009), 325-330 Review Involvement of Haptens in Allergic and Non-Allergic Hypersensitivity E. Kucharska1*, J. Bober2**, L. Jędrychowski3*** 1Department of Human Nutrition, Faculty of Food Sciences and Fisheries, West-Pomeranian University of Technology, Papieża Pawła VI no. 3, 71-459 Szczecin, Poland 2Department of Medical Chemistry, Pomeranian Medical University, Powstańców Wlkp. 72, 70-111 Szczecin, Poland 3Institute of Animal Reproduction and Food Research of the Polish Academy of Sciences in Olsztyn, Tuwima 10, 10-747 Olsztyn, Poland Received: 7 July 2008 Accepted: 11 December 2008 Abstract The environment is used as a broad umbrella term for all sources of allergens which may cause allergic hypersensitive reaction of the immune system of humans. Westernization of life leads to increased average consumption of food additives (natural and xenobiotics) – starting from over 5kg (10lbs) annually with a strong tendency to intensify. Modern technologies of food production often employ substances improving quality, texture, colour, taste, acidity or alkalinity. Haptens present in food or drugs, penetrating organism via gastrointestinal tract, may be responsible for symptoms not only in the gastrointestinal tract itself, but also in peripheral organs. Mechanisms of hapten action within human body are different – they include reactions when the immune system is involved (allergic hypersensitivity) and not involved (food intolerance also known as non-allergic hypersensitivity). Food intolerance is a more frequent phenomenon diagnosed in 20-50% of cases; food allergy affecting 6-8% children and 1-2% adults. Our work elucidates mechanisms of hypersensi- tivity responses to haptens, and characterizes major haptens applied as food additives.
    [Show full text]
  • Immunostimulatory Activity of Haptenated Proteins
    Immunostimulatory activity of haptenated proteins Noah W. Palm and Ruslan Medzhitov1 Howard Hughes Medical Institute and Department of Immunobiology, Yale University School of Medicine, 300 Cedar Street, New Haven, CT 06510 Communicated by Richard A. Flavell, Yale University School of Medicine, New Haven, CT, September 30, 2008 (received for review July 15, 2008) Antigen recognition alone is insufficient for the activation of In previous studies, we investigated the role of the TLR adaptive immune responses mediated by conventional lympho- signaling pathway in the induction of adaptive immune re- cytes. Additional signals that indicate the origin of the antigen are sponses, using mice deficient in the critical TLR signaling also required. These signals are generally provided by the innate adaptor Myeloid Differentiation primary response gene 88 immune system upon recognition of conserved microbial struc- (MyD88) (9, 10). To isolate the contribution of TLRs we used a tures by a variety of pattern recognition receptors (PRRs). The single defined TLR ligand, Lipopolysaccharide (LPS), as an Toll-like receptors (TLRs) are the best-characterized family of PRRs adjuvant, and the native proteins ovalbumin (OVA) or human and control the activation of adaptive immune responses to a serum albumin (HSA), as model antigens. incomplete Freund’s variety of immunizations and infections. However, recent studies adjuvant (IFA) and aluminum hydroxide, which contain low have questioned the role of TLRs in the induction of antibody levels of contaminating
    [Show full text]
  • Monoclonal Antibodies Specific for Mercuric Ions (Hybridomas/Metals) DWANE E
    Proc. Natl. Acad. Sci. USA Vol. 89, pp. 4104-4108, May 1992 Immunology Monoclonal antibodies specific for mercuric ions (hybridomas/metals) DWANE E. WYLIE*tt, Di Lut, LARRY D. CARLSON*, RANDY CARLSONt, K. FUNDA BABACAN§, SHELDON M. SCHUSTERt¶, AND FRED W. WAGNER*II tSchool of Biological Sciences, University of Nebraska, Lincoln, NE 68588; tBioNebraska, Inc., 3940 Cornhusker Highway, Lincoln, NE 68504; §Department of Microbiology, University of Marmara, Istanbul, Turkey; IDepartment of Biochemistry and Molecular Biology, J. Hillis Miller Health Center, University of Florida, Gainesville, FL 32610; and I'Department of Biochemistry, University of Nebraska, Lincoln, NE 68583 Communicated by Clarence A. Ryan, February 6, 1992 (received for review August 8, 1991) ABSTRACT Monoclonal antibodies (mAbs) that react These observations indicate that metals can at least influ- with soluble mercuric ions have been produced by i 'ection of ence antibody specificity and, rarely, in immunopathological BALB/c mice with a hapten-carrier complex designed to conditions, can serve as haptens toward which an antibody maximize exposure of the metal to the immune system. Three response can be directed. This report describes the produc- hybridomas producing antibodies that reacted with bovine tion of monoclonal antibodies (mAbs) specific for soluble serum albumin (BSA)-glutathione-HgCI, but not with BSA- mercuric ions by immunization of BALB/c mice with a glutathione, were isolated from the spleen of a mouse given complex consisting of mercuric chloride-glutathione- multiple iqjections with glutathione-HgCl conjugated to key- keyhole limpet hemocyanin (KLH). hole limpet hemocyanin. Stable subclones were established from two of these antibodies, designated mAb 4A10 and mAb MATERIALS AND METHODS IF10.
    [Show full text]
  • I M M U N O L O G Y
    I M M U N O L O G Y B T Immunology 2 Career Avenues GATE Coaching by IITians Table of Contents Introduction to Immune System ....................................................................................................... 4 Primary and Secondary Lymphoid Organs ...................................................................................... 12 Antigen ..................................................................... 26 Cells of Immune System .................................................................................................................. 33 Major Histocompatibility Complex ................................................................................................. 48 Antigen Processing and Presentation ............................................................................................. 51 Immunoglobulins ............................................................................................................................ 53 Origin of Antibody Diversity ........................................................................................................... 64 Polyclonal and Monolclonal Antibodies .......................................................................................... 66 Complement ............................................................. 70 Antigen-Antibody Reaction ............................................................................................................. 77 Regulation of Immune Response ...................................................................................................
    [Show full text]
  • The Fate of a Hapten
    www.nature.com/scientificreports OPEN The Fate of a Hapten - From the Skin to Modifcation of Macrophage Migration Inhibitory Factor (MIF) in Received: 14 September 2017 Accepted: 31 January 2018 Lymph Nodes Published: xx xx xxxx Isabella Karlsson 1, Kristin Samuelsson2, Carl Simonsson2, Anna-Lena Stenfeldt2, Ulrika Nilsson1, Leopold L. Ilag1, Charlotte Jonsson2 & Ann-Therese Karlberg2 Skin (contact) allergy, the most prevalent form of immunotoxicity in humans, is caused by low molecular weight chemicals (haptens) that penetrate stratum corneum and modify endogenous proteins. The fate of haptens after cutaneous absorption, especially what protein(s) they react with, is largely unknown. In this study the fuorescent hapten tetramethylrhodamine isothiocyanate (TRITC) was used to identify hapten-protein conjugates in the local lymph nodes after topical application, as they play a key role in activation of the adaptive immune system. TRITC interacted with dendritic cells but also with T and B cells in the lymph nodes as shown by fow cytometry. Identifcation of the most abundant TRITC-modifed protein in lymph nodes by tandem mass spectrometry revealed TRITC-modifcation of the N-terminal proline of macrophage migration inhibitory factor (MIF) – an evolutionary well-conserved protein involved in cell-mediated immunity and infammation. This is the frst time a hapten-modifed protein has been identifed in lymph nodes after topical administration of the hapten. Most haptens are electrophiles and can therefore modify the N-terminal proline of MIF, which has an unusually reactive amino group under physiological conditions; thus, modifcation of MIF by haptens may have an immunomodulating role in contact allergy as well as in other immunotoxicity reactions.
    [Show full text]
  • Monovalent and Divalent Haptens with Dual Specificity Monoclonal Antibody Conjugates: Enhanced Divalent Hapten Affinity for Cell Bound Antibody Conjugate
    In Vitro and In Vivo Targeting of Radiolabeled Monovalent and Divalent Haptens with Dual Specificity Monoclonal Antibody Conjugates: Enhanced Divalent Hapten Affinity for Cell Bound Antibody Conjugate Jean-Marc Le Doussal, Marie Martin, Emmanuel Gautherot, Michel Delaage, and Jacques Barbet Immunotech S.A., Campus de Luminy, Marseilles, France A method of pretargeted immunolocalizationof a mouse cell subset, using dual specificity monoclonalantibody conjugates and labeled divalent haptens, is described. Conjugates were prepared by coupling F(ab')@fragments of an antibody specificfor the allelicmouse B cell antigen Lyb8.2, to Fab' fragments of an anti-2,4-dinitrophenyl antibody. Divalent and monovalent haptens were obtained by coupling dinitrophenylto peptides or to diethylene tnamine-pentaacetic acid. In vitro, divalent haptens bind with higher affinityto mouse spleen lymphocyte-bound than to excess soluble conjugate (affinityenhancement). Invivo, localizationof 1251or 111ln-labeleddivalent haptens in mouse spleen is much higher than that ofthemonovalentanalogs.Thus,usingdivalenthaptens,a newkindofspecificitytotarget cells was achieved, suggesting that affinity enhancement may improve target to background ratios in radioimmunoscintigraphy. J Nucl Med30: 1358—1366,1989 ecently, the use of low molecular weight tracers, affinity of the DSC towards the hapten. Indeed, when such as indium chelates, associated with dual specificity the affinity is too strong, the tracer is effectively trapped antibody conjugates (DSC), combining antibodies (or by excess circulating DSC: its specific localization and fragments) to the target cells with high affinity antibod its clearance are impaired (3). Ifthis affinity is too low, ies (or fragments) to the indium chelate (dissociation no specificlocalizationwould be obtained.To take constant in the nM range), has been proposed for in advantage of the theoretical potential of the method, vivo radioimmunolocalization and radioimmunother excess DSC should be removed from the circulation apy ( 1).
    [Show full text]
  • Allotype Suppression and Epitope-Specific Regulation Leonore A
    Immunology Today, vol. 4, No. 4, 1983 113 Allotype suppression and epitope-specific regulation Leonore A. Herzenberg In neonatal (A x B) F1 mice, injections of maternal (A strain) antibody tothe Ig allotype of the paternal (B) strain chronically suppress the production of antibodies with the B-strain aUotype. Here Leonore Herzenberg describes how, in such animals, thisform of suppression influences the control of antibody responses to a thymus-dependent antigen that is subsequently encountered. The 'chronic allotype-suppression' system* occupies a As we have now shown, an 'epitope-specific' regu- peculiar niche in immunoregulatory history. Although latory system* operative in all mouse strains selectively often considered esoteric, this system (see Tables I and II) controls antibody responses to individual epitopes on has actually been one of the major contributorsto the complex antigens such as DNP-KLH (2,4-dinitrophenyl development of current concepts of how antibody hapten on keyhole limpet hemocyanin). This system responses are regulated in normal animals. The initial regulates the expression (rather than the development) of acceptance of suppressor T cells as functional regulatory memory B cells; it can be induced to either persistently agents, for example, was based to a considerable extent suppress or persistently support antibody production; on the strong and specific suppression demonstrable with and it consists of a series ofIgh-restricted, epitope-specific allotype suppressor T cells in adoptive 'co-transfer' elements individually dedicated to regulating the produc- assays I 4. Furthermore, many of the commonly known tion of antibody molecules that have the same combining- properties of suppressor T cells were first identified in site specifcity and Igh constant-region structure 1218.
    [Show full text]
  • NK Cell Memory: Discovery of a Mystery
    SERIES | COMMENT SERIES | comment NK cell memory: discovery of a mystery Ulrich von Andrian recounts how an unexpected experimental result called into question a well-established concept in immunology: the mechanism of immune memory. Follow-up experiments revealed that NK cells can mediate antigen-specifc adaptive immune responses. Ulrich H. von Andrian here must have been a mistake!” As expected, instillation of DNBS into the This was my first reaction when bladder of DNFB-sensitized animals resulted “TMahmood Goodarzi showed in a vigorous CHS response — a pronounced me a most unexpected set of experimental influx of diverse lymphoid and myeloid results. It was the summer of 2003, and we leukocytes that were readily detectable in were investigating the traffic signals that histologic sections of the bladder and could mediate the recruitment of effector T cells be quantified in single-cell suspensions to peripheral sites of antigen (Ag) challenge. of dissociated bladder tissue using flow Mahmood, a postdoctoral fellow, had set out cytometry10. The appearance of this to explore this phenomenon in the murine DNBS-induced inflammatory infiltrate bladder and was finalizing experiments for required prior sensitization with DNFB, our first manuscript on this topic. Our initial indicating that it was a learned response rationale for choosing the bladder for our driven by adaptive immune cells. Indeed, studies was that the default clinical therapy Ulrich von Andrian in 2005. the leukocyte infiltrate in DNBS-challenged for non-muscle invasive bladder cancer had bladders was dominated by CD8+ T cells been the intravesical instillation of Bacillus bearing activation markers, consistent Calmette–Guerin (BCG), which results in epidermis6.
    [Show full text]
  • Characterization of Primary T Helper Cell Activation and T Helper Cell Lines Stimulated by Hapten-Modified, Cultured Langerhans Cells
    characterization of Primary T Helper Cell Activation and T Helper Cell Lines Stimulated by Hapten-modified, Cultured Langerhans Cells Conrad H auser, M .D.! Wayne M . Yokoyama, M.D., and Stephen 1. Katz, M .D ., Ph.D. Derm.atolog-y Branch. National Cancer Insritute (CH. SIK). and ubor2tory of Immunology. National Institute of Allergic and Infectious Dise.ases (WY), Nation.allnstitutes of Health, Bethesda. Maryl.and . U .S.A. It has recentl y been shown that hapten-modified cultured ation induced by cultured Langerhans cells. Restimulation of Langerhans cells are "ble to activate SInaB resting syngeneic in vitro primed T helper cells with hapten-modified cultured L3T4+ T helper cells from nonsensitized animals. Repeated Langerhans cells revealed the prese nce. within the primed T stimulation of these T cells with hapten-modified cultured helper ce ll population. of activated cells with specificiry to an Langerhans ce lls leads to the establishment of L3T4+ hap­ unrelated hapten, suggesting that, in hapten-dependent T ten-specific interleukin-4-producing T-cell Jjnes. Here we helper cell activation, hapten-nonspecific cells are activated report on further characteristics oflrimary hapten-depen­ along with those that are hapten specilic. Restimulation of a dent activ",ion of L3T4+ T cells an ofT-ceil lines derived hapten-specifi c long-term T helper cell subline using differ­ from rhem. Dendritic cell-enriched spleen cells were as able ent antigen-presenting cell types demonstrates that factors as Langerhans cells to activate nonsensitized T helper cells other than major histocompatibil ity complex class II density after hapten modification. However, M12e, a major hisco­ or ti ssue derivation of (he antigen-presenting cell playa role compatibility complex class U-positive B-ce11 line that was in tbe acti va tion of T cells in vitro.
    [Show full text]
  • New Insights Into Drug Reaction with Eosinophilia and Systemic Symptoms Pathophysiology
    REVIEW published: 04 December 2017 doi: 10.3389/fmed.2017.00179 New Insights into Drug Reaction with Eosinophilia and Systemic Symptoms Pathophysiology Philippe Musette1* and Baptiste Janela2 1 Dermatology Department, Rouen University Hospital, Rouen, France, 2 Singapore Immunology Network, Singapore, Singapore Drug reaction with eosinophilia and systemic symptoms (DRESS), also known as drug-induced hypersensitivity syndrome, is a severe type of cutaneous drug-induced eruption. DRESS may be a difficult disease to diagnose since the symptoms mimic those of cutaneous and systemic infectious pathologies and can appear up to 3 months after the initial culprit drug exposure. The symptoms of DRESS syndrome include rash development after a minimum of 3 weeks after the onset of a new medication, associated with facial edema, lymphadenopathy, and fever. Biological findings include liver abnormalities, leukocytosis, eosinophilia, atypical lymphocytosis, and reactivation of certain human herpes viruses. In DRESS, liver, kidneys, and lungs are frequently Edited by: Florence Emmanuelle involved in disease evolution. Patients with serious systemic involvement are treated Roufosse, with oral corticosteroids, and full recovery is achieved in the majority of cases. DRESS Free University of Brussels, is a rare disease, and little is known about factors that predict its occurrence. The key Belgium features of this reaction are eosinophil involvement, the role of the culprit drug, and Reviewed by: Dagmar Simon, virus reactivation that trigger an inappropriate systemic immune response in DRESS University Hospital Bern, patients. Interestingly, it was evidenced that at-risk individuals within a genetically Switzerland Ronan Desmond, restricted population shared a particular HLA loci. In this respect, a limited number of Tallaght Hospital, Ireland well-known drugs were able to induce DRESS.
    [Show full text]
  • The Nature of the Antigen Determine the Type of Immune Response
    LECTURE: 18 Title ANTIGENS AND IMMUNOGENS LEARNING OBJECTIVES: The student should be able to: • Define the antigenicity & immunogenecity. • Define the immunogen, antigen, hapten, epitope (antigenic determinant), and adjuvant. • Identify the factors that affect the antigenicity (characters of the substances which make it antigenic), such as; foreignness, chemical complexity, molecular size, dose of the antigen (high & low dose), and adjuvants (Freund’s adjuvants & Aluminum hydroxide). • Define the relation between the epitope & the antibody specificity. Also the valence of an antigen. • Explain the cross reactivity and define the antibody affinity and the avidity. • Describe the types of antigens for example; bacterial, viral, and isoantigens such as; blood grouping, MHC antigens. • Explain the organization & structure of MHC Genes & Products (MHC class II, III molecules, & I). • Identify the role of the MHC in controlling the T-Cell response. + • Explain the activation of CD8 cytotoxic T cells, & what determines that whether an antigen elicits a class II or class I restricted response. LECTURE REFRENCE: 1. TEXTBOOK: NATIONAL MEDICAL SERIES FOR INDEPENDENT STUDY. RICHARD M. HYDE. 3RD EDITION. Chapter 2. pg 23-30. 2. TEXTBOOK: JONATHAN M. AUSTYN AND KATHRYN J. WOOD Principles of Cellular and Molecular Immunology . Chapter 2. pg 63-84. 3. TEXTBOOK: ABUL K. ABBAS. ANDREW H. LICHTMAN. CELLULAR AND MOLECULAR IMMUNOLOGY. 5TH EDITION. pg 58, 216, 489. 4. TEXTBOOK: NATIONAL MEDICAL SERIES FOR INDEPENDENT STUDY. RICHARD M. HYDE. Chapter 2. pg 23-30. 1 ANTIGENS AND IMMUNOGENS I. DEFINITIONS A. Antigens. The immune response is characterized by the production of either proteins, called antibodies, or specifically reactive lymphocytes, called T cells, when an animal encounters a foreign macromolecule or cell.
    [Show full text]
  • Chapter 3. Antigens Terminology: Hapten - a Small Molecule That Is Antigenic but Not (By Itself) Immunogenic
    Chapter 3. Antigens Terminology: Hapten - a small molecule that is antigenic but not (by itself) immunogenic. Antigen : Substances that can be recognized by the surface antibody (B cells) or by the TCR when associated with MHC molecules Antibodies can be made to haptens only after the Immunogenicity VS Antigenicity: hapten is covalently conjugated to a large protein Immunogenicity – ability to induce an antibody and/or “carrier”. cell-mediated immune response Antigenicity – ability to combine with the final products of the response (antibodies and/or T cell receptor) NOTE: Most immunogenic molecules are also antigenic Figure 5.1 1 Factors that influence immunogenicity: - Foreign-ness – non-self (far apart evolutionary) 2 - Type of molecule (chemical nature) - protein > polysaccharide > lipid > nucleic acid - Size - larger molecules tend to be more immunogenic 3 -Composition - heterogeneity increases immunogenicity. - 4ry > 3ry > 2ry > 1ry structure -Degradability - protein antigens must be degraded (phagocytosis) in order to be presented to helper T cells . - Physical Form - Denatured > Native Additional factors that influence the immune response: - Genetics of the recipient (genotype - MHC) - Dosage of the antigen (optimal dose - tolerance) - Number of doses of the antigen (boosters) - Route of administration of the antigen - intravenous (spleen) - subcutaneous (lymph nodes) - intraperitoneal (lymph nodes) - oral (mucosal) - inhaled (mucosal) - Use of adjuvant 1 Commonly used adjuvants: (Table 3.3) Adjuvant : a substance that, when mixed with an antigen Alum - aluminum potassium sulfate - precipitates the antigen, and injected with it, serves to enhance the immune resulting in increased persistence of the antigen. Mild response to the antigen. granuloma. Possible mechanisms of action of adjuvants : Incomplete Freund’s adjuvant - mineral oil-based - increases - Prolong the persistence of the antigen , thus giving the persistence of the antigen, mild granuloma, and induces co- immune system more time to respond stimulatory signals.
    [Show full text]